We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current PROF market cap is 174.77M. The company's latest EPS is USD -1.3371 and P/E is -8.44.
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 1.86M | 1.6M | 1.73M | 2.01M | 1.91M |
| Operating Income | -6.84M | -6.44M | -6.56M | -8.78M | -7.48M |
| Net Income | -6.74M | -7.36M | -5.56M | -8.91M | -6.2M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 4.17M | 7.3M | 6.87M | 6.68M | 7.2M |
| Operating Income | -14.9M | -18.86M | -30.29M | -32.13M | -28.62M |
| Net Income | -15.22M | -21.62M | -30.7M | -28.67M | -28.57M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 61.24M | 56.81M | 50.44M | 43.91M | 57.38M |
| Total Liabilities | 12.51M | 12.44M | 11.88M | 12.73M | 11.52M |
| Total Equity | 48.74M | 44.37M | 38.56M | 31.18M | 45.86M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 30.06M | 104.6M | 86.78M | 64.42M | 43.91M |
| Total Liabilities | 15.69M | 7.25M | 6.16M | 12.42M | 12.73M |
| Total Equity | 14.37M | 97.35M | 80.62M | 52M | 31.18M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -5.82M | -10.94M | -15.28M | -22.3M | -5.1M |
| Investing | N/A | N/A | N/A | N/A | N/A |
| Financing | 2.14M | 2.14M | 1.96M | 1.46M | 20.38M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -15.05M | -20.57M | -22.36M | -25.8M | -22.3M |
| Investing | -189k | -350k | -593k | N/A | N/A |
| Financing | 6.6M | 87.43M | 5.95M | 7.03M | 1.46M |
| Market Cap | 174.77M |
| Price to Earnings Ratio | -8.44 |
| Price to Sales Ratio | 33.48 |
| Price to Cash Ratio | 9.19 |
| Price to Book Ratio | 7.73 |
| Dividend Yield | - |
| Shares Outstanding | 21.37M |
| Average Volume (1 week) | 36.23k |
| Average Volume (1 Month) | 29.89k |
| 52 Week Change | -44.13% |
| 52 Week High | 15.49 |
| 52 Week Low | 7.11 |
| Spread (Intraday) | 1.45 (15.68%) |
| Company Name | Profound Medical Corporation |
| Address |
2400 skymark avenue, unit 6 mississauga, ontario L4W 5K5 |
| Website | https://www.profoundmedical.com |
| Industry | blank checks (6770) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
